BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1644 results:

  • 1. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
    He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
    J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
    Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
    Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Plant-Based Diets and Disease Progression in Men With Prostate cancer.
    Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
    JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring.
    Wu L; Hu M; Li P; Man Q; Yuan Q; Zhang X; Qiu Y; Chen L; Fan J; Zhang K
    J Cancer Res Ther; 2024 Apr; 20(2):540-546. PubMed ID: 38687923
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Travel burdens to access care among children with cancer between 2016 and 2019: Analysis of a national population-based cancer registry in Japan.
    Tsutsui A; Murakami Y; Okamura S; Fujimaki T; Endo M; Ohno Y
    PLoS One; 2024; 19(4):e0300840. PubMed ID: 38625911
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for
    Li Z; Benabdallah N; Luo J; Wahl RL; Thorek DLJ; Jha AK
    J Nucl Med; 2024 May; 65(5):810-817. PubMed ID: 38575187
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.
    Newman H; Li Y; Huang YV; Elgarten CW; Myers RM; Ruiz J; Zheng DJ; Leahy AB; Aftandilian C; Arnold SD; Bona K; Gramatges MM; Heneghan MB; Maloney KW; Modi AJ; Mody RJ; Morgan E; Rubnitz J; Winick N; Wilkes JJ; Seif AE; Fisher BT; Aplenc R; Getz KD
    Cancer Med; 2024 Apr; 13(7):e6966. PubMed ID: 38572962
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Analysis of the outcome of 12 cases of facial nerve tumors].
    Shao Z; Zhou M; Yang J; Wang K
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):225-229. PubMed ID: 38433692
    [No Abstract]    [Full Text] [Related]  

  • 9. Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
    Eigler C; McDougall L; Bauman A; Bernhardt P; Hentschel M; Blackham KA; Nicolas G; Fani M; Wild D; Cordier D
    J Nucl Med; 2024 Apr; 65(4):573-579. PubMed ID: 38423782
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
    Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
    JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
    Streuer A; Jann JC; Boch T; Mossner M; Riabov V; Schmitt N; Altrock E; Xu Q; Demmerle M; Nowak V; Oblaender J; Palme I; Weimer N; Rapp F; Metzgeroth G; Hecht A; Höger T; Merz C; Hofmann WK; Nolte F; Nowak D
    Ann Hematol; 2024 Apr; 103(4):1221-1233. PubMed ID: 38413410
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
    Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
    Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
    Lee MH; Song A; Li JY
    Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Differences and Common Ground in
    Farolfi A; Armstrong WR; Djaileb L; Gafita A; Hotta M; Allen-Auerbach M; Unterrainer LM; Fendler WP; Rettig M; Eiber M; Hofman MS; Hadaschik B; Herrmann K; Czernin J; Calais J; Benz MR
    J Nucl Med; 2024 Mar; 65(3):438-445. PubMed ID: 38238041
    [No Abstract]    [Full Text] [Related]  

  • 16. Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.
    Rothrock RJ; Ozair A; Avendano MC; Herrera S; Appel H; Ramos S; Starosciak AK; Leon-Ariza DS; Rubens M; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha RR
    Trials; 2024 Jan; 25(1):41. PubMed ID: 38217032
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. treatment Patterns of bone-targeting Agents Among Solid Tumor Patients With bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018.
    Nicholson G; Carlson KB; Hernandez RK; Schenfeld J; Cadieux B; Henry D; De Sousa Barbosa VJ; Saad H
    Am J Clin Oncol; 2024 Apr; 47(4):177-184. PubMed ID: 38200688
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Qilian Formula Inhibits Tumor Cell Growth in a bone Metastasis Model of Lung cancer.
    Wang Q; Zhao B; Li J; Zhao J; Wang C; Li Q; Yang W; Xu L; Gong Y
    Integr Cancer Ther; 2023; 22():15347354231217274. PubMed ID: 38130184
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck.
    Singhrao K; Dugan CL; Calvin C; Pelayo L; Yom SS; Chan JW; Scholey JE; Singer L
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14239. PubMed ID: 38128040
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
    Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 83.